维普中文期刊产品整合服务
31篇 您的检索式:作者名="Ossenkoppele G"
    题名 作者 年代 出处 被引量
1Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics ofbarasertib(AZDll52) in patients with advanced acute myeloid leukemia显示文摘Lowenberg B Muus P Ossenkoppele G 2011Blood2011,118,23:1
2Emerging antibody-targeted therapy in leukemia and lymphoma: current concepts and clinical implications显示文摘VAN DE LOOSDRECHT A A HUIJGENS P C OSSENKOPPELE G J 2004Anti Cancer Drugs2004,15,:1
3ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination显示文摘Berge R L Oudejans J J Ossenkoppele G J 2000Clin Pathol2000,53,6:1
4Guillain-barre syndrome after autologous peripheral blood stem cell transplantation for CML显示文摘 Tissingh G Ossenkoppele G 1999Eur J Haematol1999,63,5:1
5A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes:a report from the HOVON Cooperative Group显示文摘Ossenkoppele G Holt B Verhoef G 2000Progress in growth factors2000,6,1:1
6ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination显示文摘Berge R L Oudejans J J Ossenkoppele G J 2000Clin Pathol2000,53,6:1
7Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay显示文摘Loosdrecht AA Nennie E Ossenkoppele G 1991Immunol Methods1991,141,1:1
8ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination显示文摘ten BERGE R L OUDEJANS J J OSSENKOPPELE G J 2000J Clin Pathol2000,53,:1
9The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients显示文摘OSSENKOPPELE G J GRAVELAND W J SONNEVELD P 2004Blood2004,103,8:1
10Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay显示文摘Loosdrecht A A Nennie E Ossenkoppele G 1991Immunol Methods1991,141,1:1
11Improved risk stratifiction by the integration of therevised International Prognostic Scoring System withthe Myelodysplastic Syndrome Comorbidity Index 显示文摘van Spronaen M F Ossenkoppele G J Holman R etal 2014European Journal of Cancer2014,50,18:1
12Phase 1/2 study to assess the safety,efficacy,and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia显示文摘L(o)wenberg B Muus P Ossenkoppele G 0,,23:1
13High-dose daunorubicin in older pa- tients with acute myeloid leukemia显示文摘LOWENBERG B OSSENKOPPELE G J VAN PUTTEN W 2009N Engl J Med2009,361,:1
14MRD in AML;time for redefini-tion of CR显示文摘Ossenkoppele G Schuurhuis GJ 2013Blood2013,121,12:1
15The value of fiudarabine in addition to ARA-C and G,-CSF in the treatment of patients with high-risk myelodysplastie syndromes and AML in elderly patients显示文摘Ossenkoppele G J Graveland W J Sonneveld P 2004Blood2004,103,8:1
16Treatment of multiple myeloma in elderly patients new developments显示文摘Ossenkoppele G J 1997Drugs Aging1997,11,2:1
17The value of fludarabine in addition to ARA - C and G-CSF in the treatment of patients with high - risk myelodysp lastic syndromes and AML in elderly patients 显示文摘OSSENKOPPELE G J GRAVELAND W J SONNEVELD P etal 2004Blood2004,103,8:1
18A randomized study of granulocyte colony stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes:a report from the HOVON Cooperative Group显示文摘Ossenkoppele G Holt B Verhoef G 2000Progress in growth factors2000,6,1:1
19Review of the relevance of aberrant antigen expression by flow cytometin mycloid neoplasms 显示文摘Ossenkoppele G J van de Loosdrecht AA Schuurhuis GJ 2011Br J Haematol2011,153,4:1
20Differences of cellular composition and adhesion molecule expression in 'leukemic'as compared with ' normal' human long-term bone marrow cultures显示文摘DENKERS I A BEELEN R H OSSENKOPPELE G J 1992Ann Hematol1992,64,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费